Chest Pain and CAD Risk Assessment
Patients experiencing chest pain, chest tightness, exertional dyspnea, or coronary stenosis identified at other hospitals often require further evaluation to determine whether their symptoms are related to CAD and whether additional testing or intervention is necessary. The Center integrates electrocardiography, Holter monitoring, echocardiography, coronary CTA, coronary angiography, lipid profiling, and cardiac biomarker testing to assess CAD risk, the severity of coronary stenosis, and appropriate next steps in management.

Imported Stents and Bioresorbable (Biodegradable) Stents
For patients who are candidates for coronary intervention, the Center performs coronary angiography, percutaneous coronary intervention (PCI), and stent implantation. We have access to imported coronary stents and bioresorbable stents. Device selection is based on lesion location, vessel diameter, plaque characteristics, bleeding risk, post-procedure medication requirements, and long-term patient needs. Bioresorbable stents are not suitable for all coronary lesions and are used only when approved indications, device specifications, and hospital compliance requirements are met.

IVUS/OCT Intracoronary Imaging Guidance
Coronary angiography primarily visualizes the vessel lumen; however, some complex lesions require further assessment of plaque characteristics, vessel-wall structure, and stent status. When clinically indicated, the Center uses intravascular ultrasound (IVUS) or optical coherence tomography (OCT) to assist in evaluating vessel diameter, lesion length, plaque composition, stent expansion, and stent apposition, providing detailed imaging support for device selection and interventional planning.

Complex Coronary Lesion Intervention
For calcified lesions, bifurcation lesions, long lesions, or in-stent restenosis, the interventional team evaluates the use of drug-coated balloons, rotational atherectomy, and other advanced interventional techniques. Treatment plans are individualized based on lesion characteristics, prior stenting history, cardiac and renal function, and peri-procedural risk.

Arrhythmia and Structural Cardiovascular Assessment
For patients with palpitations, bradycardia, tachycardia, abnormal Holter findings, presyncope, or adult congenital heart disease-related conditions, the Center provides comprehensive arrhythmia and structural cardiovascular evaluations, with further diagnostic testing, interventional procedures, or long-term follow-up arranged as clinically indicated.

Long-term Cardiovascular and Cerebrovascular Management
Patients with CAD, hypertension, heart failure, dyslipidemia, or post-intervention status require ongoing management of blood pressure, lipid levels, glucose control, body weight, smoking cessation, sleep health, and medication adherence. The Center integrates coronary disease management with cerebrovascular risk assessment, using prior cardiovascular and cerebrovascular events, carotid and cerebral imaging findings, atrial fibrillation risk, and metabolic parameters to guide follow-up care and medication adjustments. This approach helps avoid the isolated management of individual risk factors while ensuring comprehensive risk reduction.

Enhanced External Counterpulsation and Cardiac Rehabilitation
For suitable patients with CAD, angina, post-intervention status, or reduced exercise tolerance, the Center incorporates EECP as part of a comprehensive cardiac rehabilitation program. EECP uses sequential lower-extremity cuff inflation and deflation synchronized with the cardiac cycle to improve diastolic coronary perfusion and venous return. Before treatment, cardiac function, blood pressure, heart rhythm, vascular status, and potential contraindications are assessed. The therapy is combined with exercise prescription, nutritional guidance, medication optimization, and risk-factor management to support long-term cardiovascular health.

Screening and Assessment Services

• Evaluation of chest pain, chest tightness, palpitations, and dyspnea
• Management of hypertension, dyslipidemia, and cardiovascular risk factors
• CAD screening and long-term follow-up
• Arrhythmia and heart failure assessment
• Comprehensive cardiovascular and cerebrovascular risk evaluation
• Interpretation of coronary CTA and coronary angiography results

Intervention and Management Services

• Coronary angiography and percutaneous coronary intervention (PCI)
• Assessment for imported coronary stents and bioresorbable (biodegradable) stents
• Post-stent medication management and follow-up
• Assessment for IVUS/OCT, drug-coated balloons, and rotational atherectomy
• EECP and cardiac rehabilitation evaluation
• Long-term follow-up for chronic cardiovascular and cerebrovascular conditions